Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

$27.3 Billion Antithrombotic/Anticoagulant Drugs Market - Technologies and Global Analysis to 2021 - Research and Markets

Research and Markets
Posted on: 19 Sep 16

Research and Markets has announced the addition of the "Antithrombotic/Anticoagulant Drugs - Technologies and Global Markets" report to their offering.

This report is a comprehensive business tool designed to provide an in-depth look at antithrombotic/anticoagulant drugs for various cardiovascular applications. The geographic scope of the report is global, with a special emphasis on individual regions such as the United States, Europe, Asia-Pacific and the rest of world. The report describes the industry, its relationship to the healthcare industry and its participants and future trends.

This report provides:

  • An overview of the global market for antithrombotic/anticoagulant drugs, which is changing due to factors such as an aging population, an increase in thrombotic events, and recent advances in pharmaceuticals
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
  • Breakdowns of the market size of anticoagulants by revenue at manufacturers' sales levels, including low molecular weight heparins and oral anticoagulants, as well as breakdowns of antiplatelets and thrombin inhibitors
  • Discussion of research and development of antithrombotic/anticoagulant treatments
  • Profiles of top leaders in each of the market segments along with companies that are novel or have specific interest to the field

Categories discussed in the report include:

  • Anticoagulants.
  • Antiplatelets.
  • Thrombin inhibitors.

Key Topics Covered:

1: Introduction

2: Executive Summary

3: Industry Overview

4: Anticoagulants

5: Antiplatelets

6: Thrombin Inhibitors

7: Company Profiles

8: Appendix A: List Of Patents

9: Appendix B: Directory Of Companies Covered In This Report

Companies Mentioned

  • Abbott Laboratories
  • Armetheon Inc.
  • Astrazeneca
  • Baxter International
  • Bayer AG
  • Biovascular Inc.
  • Boehringer Ingelheim Gmbh
  • Bristol-Myers Squibb Co.
  • CSL Behring
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly
  • Emisphere Technologies
  • F. Hoffmann-La Roche AG
  • Genentech
  • Glaxosmithkline
  • Johnson & Johnson
  • Ligand Pharmaceuticals Inc.
  • The Medicines Co.
  • Merck
  • Merrion Pharmaceuticals Ltd.
  • Microbix Biosystems Inc.
  • Novartis
  • ONO Pharmaceutical Co. Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Portola Pharmaceuticals
  • Revo Biologics Inc.
  • Sanofi
  • Santa Cruz Biotechnology Inc.
  • Servier Laboratories
  • Shire Pharmaceuticals
  • Sun Pharmaceuticals
  • TEVA Pharmaceuticals Ltd.

For more information about this report visit

Related Topics: Hematological Drugs

View source version on

Business Wire

Last updated on: 19/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.